New Business Development
When customers examine the potential of new products, or new markets, IMS is there to support strategic choices. IMS insights and analytics help answer some of pharma management’s most critical new business development questions, such as:
- Which countries and therapies should we invest in now to ensure strong future growth?
- Which of the products in our pipeline should we invest in today?
- Which products have the greatest long-term potential?
For example, IMS Disease AnalyzerTM delivers accurate, detailed insights about the patterns and treatment of disease over time. This continually updated information resource gives pharma strategists a clear, long-term view of national trends and the competitive environment – key factors in making decisions about new products and new markets. And our hospital disease databases also provide a highly detailed view of clinical practice patterns and treatments in major global markets.
When a pharma company decides to launch a drug, IMS offers guidance on pricing and the possibility of out-licensing the product. We also provide assistance on physician segmentation and promotional strategies – both the media and the messages. And we help plan where and when a new drug should be introduced.
|
|
 |
To learn more about how IMS can help your company, contact us.
For regional contact information, click here.
|
|
|
|
email this page
print this page
